Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA544509
Max Phase: Preclinical
Molecular Formula: C10H10ClF4N
Molecular Weight: 219.18
Molecule Type: Small molecule
Associated Items:
ID: ALA544509
Max Phase: Preclinical
Molecular Formula: C10H10ClF4N
Molecular Weight: 219.18
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cl.NC/C(=C/F)c1cccc(C(F)(F)F)c1
Standard InChI: InChI=1S/C10H9F4N.ClH/c11-5-8(6-15)7-2-1-3-9(4-7)10(12,13)14;/h1-5H,6,15H2;1H/b8-5-;
Standard InChI Key: LCTLZBRDEKIFNM-HGKIGUAWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 219.18 | Molecular Weight (Monoisotopic): 219.0671 | AlogP: 2.97 | #Rotatable Bonds: 2 |
Polar Surface Area: 26.02 | Molecular Species: BASE | HBA: 1 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 1 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.08 | CX LogP: 2.36 | CX LogD: 0.69 |
Aromatic Rings: 1 | Heavy Atoms: 15 | QED Weighted: 0.76 | Np Likeness Score: -0.75 |
1. McDonald IA, Lacoste JM, Bey P, Palfreyman MG, Zreika M.. (1985) Enzyme-activated irreversible inhibitors of monoamine oxidase: phenylallylamine structure-activity relationships., 28 (2): [PMID:3968682] [10.1021/jm00380a007] |
Source(1):